Core Scientific Balance Sheet
NASDAQ: CORZFinanceFinance: Consumer ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Core Scientific financial position
At the end of fiscal 2025, Core Scientific reported total assets of $2.35 billion, up 59.1% from a year earlier against total liabilities of $3.31 billion. Shareholders' equity was negative at -$962.7 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $311.4 million in cash and equivalents against $1.06 billion of debt, a net debt position of $748.9 million.
The current ratio (current assets divided by current liabilities) was 1.15, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Core Scientific balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 311.38M | 836.20M | 50.41M | 15.88M | 117.87M | 8.72M |
| Receivables | — | 1.02M | 1.00M | 234.00K | 1.38M | — |
| Total Current Assets | 895.54M | 903.96M | 97.02M | 85.10M | 756.56M | — |
| Property, Plant & Equipment | 1.29B | 433.47M | 585.43M | 691.13M | 597.30M | — |
| Goodwill | — | — | 0 | 0 | 1.06B | — |
| Intangible Assets | 1.08M | — | 2.25M | 1.70M | 8.20M | — |
| Total Assets | 2.35B | 1.48B | 712.16M | 807.69M | 2.44B | 15.00K |
| Accounts Payable | 126.11M | 19.27M | 154.75M | 53.64M | 11.62M | — |
| Short-Term Debt | 0 | — | — | — | — | — |
| Total Current Liabilities | 781.40M | 134.56M | 488.42M | 186.79M | 320.29M | 400 |
| Long-Term Debt | 1.06B | 1.07B | 684.08M | 0 | 652.21M | — |
| Total Liabilities | 3.31B | 2.42B | 1.31B | 1.22B | 1.05B | 400 |
| Shareholders' Equity | -962.74M | -943.05M | -596.94M | -409.35M | 1.34B | 89.22M |
| Retained Earnings | -4.15B | -3.86B | -2.42B | -2.17B | -27.43M | -10.40K |
| Total Debt | 1.06B | 1.07B | 684.08M | 0 | 652.21M | — |
| Net Cash (Debt) | -748.95M | -237.79M | -633.67M | 15.88M | -534.34M | 8.72M |
| Shares Outstanding | 314.23M | 292.61M | 386.88M | 375.23M | 271.58M | — |
This table shows 6 annual periods of Core Scientific's balance sheet, from FY 2025 back to FY 2020, across 17 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow CORZ's reporting calendar. What is a balance sheet?